Astrazeneca equity research - big pharma on the brink of future changes in oncology

Detalhes bibliográficos
Autor(a) principal: Kerkow, Jonas Karl
Data de Publicação: 2021
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/145367
Resumo: The pharmaceutical industry is distinguished by a highly competitive market. Furthermore, various growth trends provide promising outlooks for the future development of the sector. Thus, competitors need to focus on measures such as strong R&D spending to be able to defend their positioning in the industry. These prospects compose the basis for further expansion while we assess two possible outcomes.
id RCAP_003a68519f3fce6feaf58c6d36e3e622
oai_identifier_str oai:run.unl.pt:10362/145367
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Astrazeneca equity research - big pharma on the brink of future changes in oncologyValuationFinanceDomínio/Área Científica::Ciências Sociais::Economia e GestãoThe pharmaceutical industry is distinguished by a highly competitive market. Furthermore, various growth trends provide promising outlooks for the future development of the sector. Thus, competitors need to focus on measures such as strong R&D spending to be able to defend their positioning in the industry. These prospects compose the basis for further expansion while we assess two possible outcomes.André, RosárioRUNKerkow, Jonas Karl2022-11-09T17:04:20Z2022-09-152021-12-172022-09-15T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/145367TID:203082770enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:25:42Zoai:run.unl.pt:10362/145367Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:52:02.947691Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Astrazeneca equity research - big pharma on the brink of future changes in oncology
title Astrazeneca equity research - big pharma on the brink of future changes in oncology
spellingShingle Astrazeneca equity research - big pharma on the brink of future changes in oncology
Kerkow, Jonas Karl
Valuation
Finance
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
title_short Astrazeneca equity research - big pharma on the brink of future changes in oncology
title_full Astrazeneca equity research - big pharma on the brink of future changes in oncology
title_fullStr Astrazeneca equity research - big pharma on the brink of future changes in oncology
title_full_unstemmed Astrazeneca equity research - big pharma on the brink of future changes in oncology
title_sort Astrazeneca equity research - big pharma on the brink of future changes in oncology
author Kerkow, Jonas Karl
author_facet Kerkow, Jonas Karl
author_role author
dc.contributor.none.fl_str_mv André, Rosário
RUN
dc.contributor.author.fl_str_mv Kerkow, Jonas Karl
dc.subject.por.fl_str_mv Valuation
Finance
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
topic Valuation
Finance
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
description The pharmaceutical industry is distinguished by a highly competitive market. Furthermore, various growth trends provide promising outlooks for the future development of the sector. Thus, competitors need to focus on measures such as strong R&D spending to be able to defend their positioning in the industry. These prospects compose the basis for further expansion while we assess two possible outcomes.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-17
2022-11-09T17:04:20Z
2022-09-15
2022-09-15T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/145367
TID:203082770
url http://hdl.handle.net/10362/145367
identifier_str_mv TID:203082770
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138112409960448